Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli
暂无分享,去创建一个
N. Tjandra | Kang Chen | T. Xiao | T. Miethke | N. Snyder | Jiansheng Jiang | Patrick T Smith | Franziska Römmler | Anna Waldhuber | S. Dürr | T. Fresquez | G. Snyder | C. Cirl | Patrick T. Smith
[1] M. Shirakawa,et al. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling. , 2012, Molecular immunology.
[2] S. Vogel,et al. Targeting Toll-like Receptor (TLR) Signaling by Toll/Interleukin-1 Receptor (TIR) Domain-containing Adapter Protein/MyD88 Adapter-like (TIRAP/Mal)-derived Decoy Peptides* , 2012, The Journal of Biological Chemistry.
[3] A. Bowie,et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. , 2012, Immunity.
[4] Weihong Zhou,et al. Structural Insights into TIR Domain Specificity of the Bridging Adaptor Mal in TLR4 Signaling , 2012, PloS one.
[5] C. Tung,et al. The Brucella TIR-like protein TcpB interacts with the death domain of MyD88. , 2012, Biochemical and biophysical research communications.
[6] Anne-Sophie de Smet,et al. Identification of Interaction Sites for Dimerization and Adapter Recruitment in Toll/Interleukin-1 Receptor (TIR) Domain of Toll-like Receptor 4* , 2011, The Journal of Biological Chemistry.
[7] S. Cusack,et al. Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA , 2011, Cell.
[8] P. Simpson,et al. Yersinia pestis TIR-domain protein forms dimers that interact with the human adaptor protein MyD88. , 2011, Microbial pathogenesis.
[9] F. DiMaio,et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection , 2011, Proceedings of the National Academy of Sciences.
[10] J. Lakowicz,et al. Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface , 2011, The Journal of Immunology.
[11] B. Kobe,et al. Structural and functional analysis of a plant resistance protein TIR domain reveals interfaces for self-association, signaling, and autoregulation. , 2011, Cell host & microbe.
[12] Joseph M. Connors,et al. Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.
[13] T. Miethke,et al. Inhibition of TIR Domain Signaling by TcpC: MyD88-Dependent and Independent Effects on Escherichia coli Virulence , 2010, PLoS pathogens.
[14] T. Miethke,et al. Microbial Toll/interleukin 1 receptor proteins: a new class of virulence factors. , 2010, International journal of medical microbiology : IJMM.
[15] T. Xiao. Subversion of Innate Immune Signaling Through Molecular Mimicry , 2010, Journal of Clinical Immunology.
[16] Y. Lo,et al. Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.
[17] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[18] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[19] E. Santelli,et al. The crystal structure of a TIR domain from Arabidopsis thaliana reveals a conserved helical region unique to plants , 2009, Protein science : a publication of the Protein Society.
[20] M. Shirakawa,et al. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling , 2009, Proceedings of the National Academy of Sciences.
[21] G. Splitter,et al. Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP* , 2009, Journal of Biological Chemistry.
[22] N. Klopp,et al. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk , 2009, Allergy.
[23] P. Nordlund,et al. The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer* , 2008, Journal of Biological Chemistry.
[24] A. Wieser,et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins , 2008, Nature Medicine.
[25] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[26] R. Ugalde,et al. Brucella Control of Dendritic Cell Maturation Is Dependent on the TIR-Containing Protein Btp1 , 2008, PLoS pathogens.
[27] K. Shibata,et al. Regulation of MyD88-Dependent Signaling Events by S Nitrosylation Retards Toll-Like Receptor Signal Transduction and Initiation of Acute-Phase Immune Responses , 2007, Molecular and Cellular Biology.
[28] Grazia Gallo,et al. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound , 2007, Journal of leukocyte biology.
[29] John Calvin Reed,et al. Characterization of a TIR-like protein from Paracoccus denitrificans. , 2007, Biochemical and biophysical research communications.
[30] A. Bowie,et al. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.
[31] M. Fenton,et al. Cutting Edge: Differential Inhibition of TLR Signaling Pathways by Cell-Permeable Peptides Representing BB Loops of TLRs1 , 2007, The Journal of Immunology.
[32] Giorgio Sirugo,et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.
[33] Ashish,et al. Structural and Functional Evidence for the Role of the TLR2 DD Loop in TLR1/TLR2 Heterodimerization and Signaling* , 2006, Journal of Biological Chemistry.
[34] I. Wilson,et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Fields,et al. Binding specificity of Toll‐like receptor cytoplasmic domains , 2006, European journal of immunology.
[36] Ruchi M. Newman,et al. Identification and Characterization of a Novel Bacterial Virulence Factor That Shares Homology with Mammalian Toll/Interleukin-1 Receptor Family Proteins , 2022 .
[37] J. Hawiger,et al. Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* , 2005, Journal of Biological Chemistry.
[38] M. Fenton,et al. Differential Involvement of BB Loops of Toll-IL-1 Resistance (TIR) Domain-Containing Adapter Proteins in TLR4- versus TLR2-Mediated Signal Transduction 1 , 2005, The Journal of Immunology.
[39] Zukang Feng,et al. Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank. , 2004, Acta crystallographica. Section D, Biological crystallography.
[40] J. Khan,et al. Crystal Structure of the Toll/Interleukin-1 Receptor Domain of Human IL-1RAPL* , 2004, Journal of Biological Chemistry.
[41] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[42] I. Bataronov,et al. Processing of X-Ray Diffraction Data in Structure Investigations of Amorphous Metal Oxides , 2004 .
[43] N. Gay,et al. Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.
[44] G. Cheng,et al. Common Interaction Surfaces of the Toll-Like Receptor 4 Cytoplasmic Domain Stimulate Multiple Nuclear Targets , 2003, Molecular and Cellular Biology.
[45] A. Aderem,et al. Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1 , 2003, The Journal of Immunology.
[46] J. Banchereau,et al. Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.
[47] Liang Tong,et al. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. , 2002, Biochemical and biophysical research communications.
[48] Dirk E. Smith,et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.
[49] L. Tong,et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.
[50] S. Dower,et al. Identification of Two Major Sites in the Type I Interleukin-1 Receptor Cytoplasmic Region Responsible for Coupling to Pro-inflammatory Signaling Pathways* , 2000, The Journal of Biological Chemistry.
[51] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[52] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[53] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[54] F. Martinon,et al. MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.
[55] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[56] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.